mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.05 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.05 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.05 |
mRNA |
sotrastaurin |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.05 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.05 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.05 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.05 |
mRNA |
BRD-K55116708 |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.06 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.06 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.06 |